Duquesne Family Office’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.24M | Hold |
|
|||||
|
2022
Q3 | $1.48M | Hold |
|
|||||
|
2022
Q2 | $1.79M | Hold |
|
|||||
|
2022
Q1 | $1.93M | Sell |
|
|||||
|
2021
Q4 | $10.7M | Sell |
|
|||||
|
2021
Q3 | $69.9M | Buy |
|
|||||
|
2021
Q2 | $90.2M | Sell |
|
|||||
|
2021
Q1 | $74.8M | Hold |
|
|||||
|
2020
Q4 | $92.7M | Buy |
|
|||||
|
2020
Q3 | $53M | Buy |
|
|||||
|
2020
Q2 | $83.1M | Buy |
|
|||||
|
2020
Q1 | $76.8M | Buy |
|
|||||
|
2019
Q4 | $87.2M | Buy |
|
|||||
|
2019
Q3 | $13.9M | Buy |
|